AIM Vaccine Co., Ltd. (6660.HK)

HKD 3.4

(3.66%)

Operating Income Summary of AIM Vaccine Co., Ltd.

  • AIM Vaccine Co., Ltd.'s latest annual operating income in 2023 was -3.51 Billion CNY , down -70.75% from previous year.
  • AIM Vaccine Co., Ltd.'s latest quarterly operating income in 2024 Q2 was -142.08 Million CNY , up 95.56% from previous quarter.
  • AIM Vaccine Co., Ltd. reported an annual operating income of -384.33 Million CNY in 2022, up 34.83% from previous year.
  • AIM Vaccine Co., Ltd. reported an annual operating income of -589.69 Million CNY in 2021, down -217.16% from previous year.
  • AIM Vaccine Co., Ltd. reported a quarterly operating income of -310.11 Million CNY for 2023 Q2, down -1.28% from previous quarter.
  • AIM Vaccine Co., Ltd. reported a quarterly operating income of -3.2 Billion CNY for 2023 Q4, down -932.59% from previous quarter.

Annual Operating Income Chart of AIM Vaccine Co., Ltd. (2023 - 2019)

Historical Annual Operating Income of AIM Vaccine Co., Ltd. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 -3.51 Billion CNY -70.75%
2022 -384.33 Million CNY 34.83%
2021 -589.69 Million CNY -217.16%
2020 503.34 Million CNY 212.48%
2019 161.08 Million CNY 0.0%

Peer Operating Income Comparison of AIM Vaccine Co., Ltd.

Name Operating Income Operating Income Difference
Uni-Bio Science Group Limited 67.76 Million HKD 5282.843%
CK Life Sciences Int'l., (Holdings) Inc. 897.95 Million HKD 491.146%